vizz
Generic: aceclidine·Code: LNZ100
vizz: developed by 1 company · 1 FDA decision.
vizz evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect vizz to LENZ; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could vizz → LENZ affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| LENZ Therapeutics, Inc. (LENZ) | Approved |
FDA Decisions1 records
Frequently asked questions
Who is developing vizz?
vizz is being developed by LENZ Therapeutics, Inc..
What is vizz's latest FDA decision?
The most recent tracked FDA decision for vizz is Approval for 1 INDICATIONS AND USAGE VIZZ is indicated for the treatment of presbyopia in adults. VIZZ is a cholinergic agonist indicated for the treatment of presbyopia in adults ( 1 )., dated July 31, 2025.